| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f84747e8d08b1023763356d0e7d1db68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2787f8eb17e2cb2486db5efc8fa0cc9b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2799-021 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-05 |
| filingDate |
1998-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2003-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e2db6dbb39ff2dcd207a81945c44a25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c70dc95688bef956b33fa1f904eaecc6 |
| publicationDate |
2003-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2214280-C2 |
| titleOfInvention |
Methods and components for induction of tumor- -specific cytotoxicity |
| abstract |
FIELD: medicinal genetics, oncology. SUBSTANCE: invention relates to method for expression of heterologous sequence in tumor cell by insertion of gene into cell subjected for imprinting. Gene comprises regulatory sequence, for example, H19 with promoter P3 or P4 IGF-2 and others that is able to operate the expression of cytotoxic products. Genes can be used for treatment of different cancer, viral and autoimmune disease. Description of invention comprises data concerning the corresponding expression vectors and methods of treatment. EFFECT: expanded arsenal of agents in genetic therapy. 40 cl, 10 dwg, 10 ex |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2511395-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9758766-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-016223-B1 |
| priorityDate |
1997-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |